ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 646848 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 646848; 2) Community: the network communities that were significantly associated with the response to NSC 646848; 3) Molecule: the relationships between components within communities and NSC 646848; 4) MDR: the compounds that were significantly associated with the NSC 646848.

NSC Compound Enrichment Correlation
NSC 724784 (1S,4R,5R,8R,12R,13S)-1,5-dimethyl-9-methylene-11,14,15,16-t etraoxatetracyclo[10.3.1.04,13.08,13]hexadec-10-yl]oxy}-3-he xenyl)oxy]-1,5,-dimethyl-9-methylene-11,14,15,16-tetraoxatet racyclo[10.3.1.0 0.0361455178924428 0.081502541
NSC 735946 N-(4'-Hydroxy-3'-methoxycinnamoyl)-17a-aminomethyl-estra-1,3 ,5(10)-trien-3,17b-diol 0.0361455178924428 0.31104533
NSC 101003 Null 0.0361455178924431 0.29538787
NSC 11241 C.I. Basic Red 6 0.0361455178924431 0.20847094
NSC 174121 Methotrexate Derivative 0.0361455178924431 0.33816312
NSC 191924 Null 0.0361455178924431 0.21538626
NSC 271674 Carboxyphthalatoplatinum 0.0361455178924431 0.42314973
NSC 30637 Null 0.0361455178924431 0.052993908
NSC 319447 Null 0.0361455178924431 0.085231764
NSC 324979 Copper, chloro[hexahydro-1H-azepine-1-carbothioic acid [1-(2-pyridinyl)ethylidene]hydrazidato]-, (SP-4-3)- 0.0361455178924431 0.37394184
Total:130  Current:107    [First] [Prev] [Next] [Last]